Epidermal Growth Factor Receptor (EGFR) Ubiquitination as a Mechanism of Acquired Resistance Escaping Treatment by the Anti-EGFR Monoclonal Antibody Cetuximab. Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

Published in

  • Cancer Research

Time

Date/time value

  • 2007

Identity

Digital Object Identifier (DOI)

  • 10.1158/0008-5472.CAN-07-0589

Additional Document Info

Parent Title

  • Cancer Research

Volume

  • 67

Issue

  • 17

Publisher

  • American Association for Cancer Research